GeriPal
OCTOBER 5, 2023
I felt like I was always told to present people with a buffet of options and, really, without guidance, ask them to choose, which is, it would always make me feel sick to my stomach. And I worry, I’m not sure that appealing to, we haven’t engaged in complete informed consent if we haven’t done this.
Pallimed
SEPTEMBER 12, 2022
In September 2021, Pallimed published our second commentary, which focused on the astonishing disclosure of an important conflict-of-interest (COI) by Dr. Roger Chou (5), who co-authored the 2016 Guideline, calling its integrity into question (4, 5).
Healthcare Law Insights blog
JUNE 30, 2023
FDA explains that investigational products that use plant material, algae, or macroscopic fungi may be considered a botanical, and are covered by FDA’s December 2016 “Botanical Drug Development” guidance. For one, the use of an inert placebo may present a challenge.
Expert insights. Personalized for you.
265 
Let's personalize your content